Ignite Creation Date:
2025-12-24 @ 10:35 PM
Ignite Modification Date:
2026-02-22 @ 7:23 AM
Study NCT ID:
NCT02380235
Status:
UNKNOWN
Last Update Posted:
2017-06-16
First Post:
2015-03-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I)
Sponsor:
Changchun GeneScience Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-12
Start Date Type:
None
Primary Completion Date:
2017-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2017-07
Completion Date Type:
ESTIMATED
First Submit Date:
2015-03-02
First Submit QC Date:
None
Study First Post Date:
2015-03-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-14
Last Update Post Date:
2017-06-16
Last Update Post Date Type:
ACTUAL